Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment

Lupus

Volumn 19, Issue 13, 2010, Pages 1550-1556

  Otten, M H ^a   Cransberg, K ^a   Van Rossum, M A J ^b   Groothoff, J W ^b   Kist Van Holthe, J E ^c   Ten Cate, R ^c   Van Suijlekom Smit, L W A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Disease activity patterns; Disease course; Early aggressive treatment; Flare rate; Juvenile Systemic Lupus Erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; EARLY INTERVENTION; ETHNICITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; NETHERLANDS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78649310391     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310374485     Document Type: Article

References (21)

1. Benseler SM, Silverman ED Systemic lupus erythematosus. Pediatr Clin North Am 2005 ; 52: 443-467.
2. Petri M., Buyon J., Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999 ; 8: 685-691.
3. Barr SG, Zonana-Nacach A., Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 2682-2688.
4. van Rossum MA, van Soesbergen RM, Boers M., et al. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis 2007 ; 66: 1518-1524.
5. Albers HM, Wessels JA, van der Straaten RJ, et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 200 9; 15 (61). 46-51.
6. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277.
7. Weiss JE, Sison CP, Ilowite NT, Gottlieb BS, Eberhard BA Flares in pediatric systemic lupus erythematosus. J Rheumatol 2007 ; 34: 1341-1344.
8. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35: 630-640.
9. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004 ; 114: 555-576.
10. Cassidy JT, Sullivan DB, Petty RE, Ragsdale C. Lupus nephritis and encephalopathy. Prognosis in 58 children. Arthritis Rheum 1977 ; 20: 315-322.
11. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000 ; 27: 373-376.
12. Johnson SR, Urowitz MB, Ibanez D., Gladman DD Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol 2006 ; 33: 1990-1995.
13. Sutcliffe N., Clarke AE, Gordon C., Farewell V., Isenberg DA The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999 ; 38: 1130-1137.
14. Fernandez M., Alarcon GS, Calvo-Alen J., et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007 ; 15 (57). 576-584.
15. Sule S., Petri M. Socioeconomic status in systemic lupus erythematosus. Lupus 2006 ; 15: 720-723.
16. Hiraki LT, Benseler SM, Tyrrell PN, Harvey E., Hebert D., Silverman ED Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009 ; 36: 2539-2546.
17. Jurencak R., Fritzler M., Tyrrell P., Hiraki L., Benseler S., Silverman E. Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 2009 ; 36: 416-421.
18. Hersh AO, von Scheven E., Yazdany J., et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 2009 ; 15: 61 13-20.
19. Zonana-Nacach A., Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000 ; 43: 1801-1808.
20. Bader-Meunier B., Armengaud JB, Haddad E., et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005 ; 146: 648-653.
21. King KK, Kornreich HK, Bernstein BH, Singsen BH, Hanson V. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 1977 ; 20: 287-294.